Image credit: Canva
Non-Hodgkin lymphomas are aggressive blood cancers that can be difficult to treat and may return after treatment. People with HIV are up to 17 times more likely to get non-Hodgkin lymphomas than people who do not have HIV. A clinical trial led by Kathryn A. Lurain, M.D., M.P.H., Assistant Research Physician in the HIV and AIDS Malignancies Branch, is researching a combination drug therapy for the blood cancer. The trial will take place at the NIH Clinical Center in Bethesda, Maryland, and there is no cost for participation.
For more information, please contact Anaida Widell at (240) 760-6074 or anaida.widell@nih.gov.
Clinicaltrials.gov identifier: NCT05389423
NCI Protocol ID: 000274
Official Title: Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
The Center for Cancer Research is NCI’s internal cancer center, a publicly funded organization working to improve the lives of cancer patients by solving important, challenging and neglected problems in cancer research and patient care. Highly trained physician-scientists develop and carry out clinical trials to create the medicines of tomorrow treating patients at the world’s largest dedicated research hospital on the campus of the National Institutes of Health in Bethesda, Maryland.
For more information on CCR clinical trials click here, and subscribe to have the latest CCR clinical trials sent directly to your inbox.